Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia Provided by GlobeNewswire May 14, 2025, 1:05:00 PM ...

The poster will expand upon the topline data that was reported from this population in December 2024. A poster presentation reporting outcomes in patients with R/R NUP98r acute leukemias in the ...

These data were presented in three posters at the 24 th European Hematology Association (EHA) Congress, taking place June 13-16 in Amsterdam.

Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress Published May 14, 2024 10:00am EDT ...

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the ...

Details of the poster presentation are as follows: Title: ADI-270: An Armored Allogeneic Anti-CD70 CAR γδ T Cell Therapy Designed for Multiple Solid and Hematological Cancer Indications ...